Cargando…

Inhibition of APOE potentiates immune checkpoint therapy for cancer

Checkpoint immunotherapy is capable of unleashing T cells for controlling tumor, whereas it is destroyed by immunosuppressive myeloid cell. Apoprotein E (APOE) refers to a ligand in terms of the members of low-density lipoprotein (LDL) receptor family for mediating Apoprotein B-involving atherogenic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hui, Bingqing, Lu, Chen, Li, Haiyang, Hao, Xiaopei, Liu, Hanyuan, Zhuo, Danping, Wang, Qian, Li, Zhouxiao, Liu, Li, Wang, Xuehao, Gu, Yanhong, Tang, Weiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461658/ https://www.ncbi.nlm.nih.gov/pubmed/36147474 http://dx.doi.org/10.7150/ijbs.70117

Ejemplares similares

Tegaserod Maleate Inhibits Breast Cancer Progression and Enhances the Sensitivity of Immunotherapy
por: Li, Xiao, et al.
Publicado: (2022)

Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing
por: Hao, Xiaopei, et al.
Publicado: (2022)

CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ
por: Hao, Xiaopei, et al.
Publicado: (2022)

Inhibition of PARP Potentiates Immune Checkpoint Therapy through miR-513/PD-L1 Pathway in Hepatocellular Carcinoma
por: Sun, Guoqiang, et al.
Publicado: (2022)

GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway
por: Rong, Dawei, et al.
Publicado: (2023)

Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges
por: Hao, Xiaopei, et al.
Publicado: (2021)

The emerging landscape of circular RNAs in immunity: breakthroughs and challenges
por: Li, Zhouxiao, et al.
Publicado: (2020)

Single-cell RNA-sequencing atlas reveals an FABP1-dependent immunosuppressive environment in hepatocellular carcinoma
por: Tang, Weiwei, et al.
Publicado: (2023)

Health literacy and functional exercise adherence in postoperative breast cancer patients
por: Tang, Weiwei, et al.
Publicado: (2017)

Extracellular RNA in melanoma: Advances, challenges, and opportunities
por: Li, Zhouxiao, et al.
Publicado: (2023)

Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy
por: Sun, Guangshun, et al.
Publicado: (2022)

Single-cell RNA sequencing of immune cells in gastric cancer patients
por: Fu, Kai, et al.
Publicado: (2020)

A 3D multi-modal intelligent intervention system using electromagnetic navigation for real-time positioning and ultrasound images: a prospective randomized controlled trial
por: Tang, Weiwei, et al.
Publicado: (2022)

PCSK9 inhibition potentiates cancer immune checkpoint therapy
por: Liu, Xinjian, et al.
Publicado: (2020)

Successful immune checkpoint inhibitor‐based rechallenge in a patient with advanced esophageal squamous cell cancer: A case report
por: Yao, Yanhong, et al.
Publicado: (2022)

Prospects for combining immune checkpoint blockade with PARP inhibition
por: Li, Anping, et al.
Publicado: (2019)

MGP promotes CD8(+) T cell exhaustion by activating the NF-κB pathway leading to liver metastasis of colorectal cancer
por: Rong, Dawei, et al.
Publicado: (2022)

Treatment-related adverse events and response rate to immune checkpoint inhibition
por: Li, Yanmin, et al.
Publicado: (2019)

Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Progress, Challenges, and Prospects
por: Tang, Shengjie, et al.
Publicado: (2022)

STK39 enhances the progression of Cholangiocarcinoma via PI3K/AKT pathway
por: Hao, Xiaopei, et al.
Publicado: (2021)

Could Inhibiting the DNA Damage Repair Checkpoint Rescue Immune-Checkpoint-Inhibitor-Resistant Endometrial Cancer?
por: Li, Yinuo, et al.
Publicado: (2023)

Overexpression of lncRNA AFAP1-AS1 promotes cell proliferation and invasion in gastric cancer
por: Li, Zhouxiao, et al.
Publicado: (2019)

The Cholinergic Anti-Inflammatory Pathway Attenuates the Development of Atherosclerosis in Apoe(-/-) Mice through Modulating Macrophage Functions
por: Qian, Zhengjiang, et al.
Publicado: (2021)

Inhibition of myeloperoxidase enhances immune checkpoint therapy for melanoma
por: Liu, Tracy W, et al.
Publicado: (2023)

Inhibition of JAK2 Suppresses Myelopoiesis and Atherosclerosis in Apoe(−/−) Mice
por: Tang, Yang, et al.
Publicado: (2020)

Intracranial radiotherapy with or without immune checkpoint inhibition for brain metastases: a systematic review and meta-analysis
por: He, Qian, et al.
Publicado: (2020)

Potential role of ATM in hepatocyte endocytosis of ApoE-deficient, ApoB48-containing lipoprotein in ApoE-deficient mice
por: WU, JIANHUA, et al.
Publicado: (2014)

Immune Checkpoint Inhibitor Toxicity in Head and Neck Cancer: From Identification to Management
por: Wang, Haiyang, et al.
Publicado: (2019)

NK Cell-Based Immune Checkpoint Inhibition
por: Khan, Muhammad, et al.
Publicado: (2020)

Hypofractionated Low-Dose Radiotherapy Combined with Immune Checkpoint Inhibition in Metastatic Solid Tumors
por: Li, Dongqing, et al.
Publicado: (2021)

Management of immune checkpoint inhibitor‐related rheumatic adverse events
por: Zhou, Jiaxin, et al.
Publicado: (2019)

Novel insights into circular RNAs in clinical application of carcinomas
por: Rong, Dawei, et al.
Publicado: (2017)

Liver kinase B1 in exosomes inhibits immune checkpoint programmed death ligand 1 and metastatic progression of intrahepatic cholangiocarcinoma
por: Liu, Zhuo, et al.
Publicado: (2022)

Epitope Spreading and the Efficacy of Immune Checkpoint Inhibition in Cancer
por: Liu, W. Robert, et al.
Publicado: (2021)

Immune desert in MMR-deficient tumors predicts poor responsiveness of immune checkpoint inhibition
por: Zheng, Guoxing, et al.
Publicado: (2023)

Immune landscape and the key role of APOE+ monocytes of lupus nephritis under the single‐cell and spatial transcriptional vista
por: Tang, Youzhou, et al.
Publicado: (2023)

Impact of endogenous glucocorticoid on response to immune checkpoint blockade in patients with advanced cancer
por: Cui, Yu, et al.
Publicado: (2023)

Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade
por: Lei, Yanna, et al.
Publicado: (2021)

A Highlight of the Mechanisms of Immune Checkpoint Blocker Resistance
por: Huang, Qian, et al.
Publicado: (2020)

Current Perspectives on B Lymphocytes in the Immunobiology of Hepatocellular Carcinoma
por: Qin, Miaomiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lvae2huhro3bkcmh983obq3uv3